October 24, 2007 – Researchers for the Radiation Therapy Oncology Group (RTOG) have found that emotional well-being is not an independent factor in predicting the survival time of patients with head and neck cancer.

The details of their research appear in the Dec. 1 issue of CANCER.

The investigators examined survival and quality of life data from two large RTOG multicenter clinical trials. Patients enrolled in the trials completed a baseline measure of quality of life that included an Emotional Well-Being subscale. The combined data set of approximately 1100 patients and 650 deaths allowed the researchers to make correlations between survival and emotional well-being, as well several other more predictive factors, on one of the largest pools of patients with uniformity of cancer site, treatment, quality of care, and quality of life reporting.

For more information: www.rtog.org


Additional Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
Subscribe Now